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ABSTRACT 
 
Objective To assess whether foot and/or ankle symptoms are associated with an increased risk of 
worsening of knee pain and radiographic change in people with knee osteoarthritis (OA). 
Methods The presence and laterality of foot/ankle symptoms were recorded at baseline in 1368 
participants from the Osteoarthritis Initiative with symptomatic radiographic knee OA. Knee 
pain severity (measured using the Western Ontario and McMaster Universities Osteoarthritis 
Index pain subscale) and minimum medial tibiofemoral joint space (minJSW) width measured on 
x-ray were assessed yearly over the subsequent four years. Associations between foot/ankle 
symptoms and worsening of (i) knee pain, and (ii) both knee pain and minJSW (i.e. symptomatic 
radiographic knee OA) were assessed using logistic regression.  
Results Foot/ankle symptoms in either foot/ankle significantly increased the odds of knee pain 
worsening (adjusted OR 1.54, 95% CI 1.25 to 1.91). Laterality analysis showed ipsilateral 
(adjusted OR 1.50, 95% CI 1.07 to 2.10), contralateral (adjusted OR 1.44, 95% CI 1.02 to 2.06) 
and bilateral foot/ankle symptoms (adjusted OR 1.61, 95% CI 1.22 to 2.13) were all associated 
with knee pain worsening in the follow up period. There was no association between foot/ankle 
symptoms and worsening of symptomatic radiographic knee OA. 
Conclusion The presence of foot/ankle symptoms in people with symptomatic radiographic knee 
OA was associated with increased risk of knee pain worsening, but not worsening of 
symptomatic radiographic knee OA, over the subsequent four years. Future studies should 
investigate whether treatment of foot/ankle symptoms reduces the risk of knee pain worsening in 
people with knee OA.  
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Knee osteoarthritis (OA) is a major public health problem that causes substantial pain, physical 
dysfunction and impaired quality-of-life. There is no cure for knee OA and the disease often 
progresses to advanced stages. Although there is a discordance between knee pain and joint 
deterioration1, both are drivers of costly joint replacement surgery2. Therefore, it is important to 
identify risk factors that are associated with the worsening of knee symptoms, with and without 
concurrent structural deterioration, in an attempt to prevent disease progression. 
 
Researchers have identified a number of risk factors for the worsening of knee OA symptoms 
and structure, such as age, ethnicity and malalignment3, 4, however modifiable risk factors are 
required to prevent progression to advanced disease and/or surgery. To date, the strongest known 
modifiable risk factors for worsening of knee pain in people with knee OA are a higher body 
mass index (BMI) and infrapatellar fat pad or intercondylar synovitis4, whilst a recent meta-
analysis identified greater knee pain at baseline as the only modifiable risk factor associated with 
structural progression3. Although these risk factors are potentially modifiable, weight loss 
interventions have poor compliance and limited long-term success5 and the remaining risk 
factors are likely to be symptoms or sequelae of OA and thus it is unclear whether targeted 
treatment would slow disease progression. 
  
A potential risk factor for worsening knee OA that has not been investigated is foot/ankle 
symptoms. Concurrent symptoms at the foot, ankle and knee occur more often than any other 
multi-joint pain presentation, and their co-occurrence substantially increases the risk of problems 
with walking, standing and rising from sitting compared to single- and other multi-joint 
symptoms6. In people with knee OA, cross-sectional studies have shown that the presence of 
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foot/ankle symptoms is also associated with worse knee symptoms, health-related quality-of-life, 
depressive symptoms and functional abilities7. More recently, our longitudinal study showed that 
foot/ankle symptoms are an independent risk factor for developing knee OA in people free of the 
disease but at risk 8. Potential mechanisms linking foot/ankle symptoms and incident knee OA, 
such as foot pronation, inappropriate footwear or widespread pain8, may also increase the risk for 
worsening in those with OA. However, as incident disease is a different phenomenon to 
worsening OA and risk factors may not be consistent across both, it is necessary to separately 
establish the association of foot/ankle symptoms with worsening OA.  This is important as worse 
knee pain and greater radiographic severity are predictors of progression to arthroplasty2. 
Knowledge of risk factors in those with knee OA can provide insight into why the disease 
progresses in some individuals but not others and help identify potential new treatment targets 
for future clinical trials10. Therefore, the aim of this study was to investigate whether the 
presence of foot/ankle symptoms at baseline is associated with an increased risk of worsening of 
(i) knee pain, and (ii) both knee pain and radiographic change, in people with symptomatic 
radiographic knee OA.  
 
METHODS 
Study population 
Data were obtained from the Osteoarthritis Initiative (OAI), an online and publically available 
database (http://www.oai.ecsf.edu/). The OAI is a prospective multi-centre cohort study of 4796 
participants aged between 45-79 years who have existing knee OA, or who are considered at-risk 
of the disease. The participants were recruited from four sites throughout the United States 
including Baltimore, Maryland; Columbus, Ohio; Pittsburgh, Pennsylvania; and Pawtucket, 
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Rhode Island. The institutional review board at each site approved all protocols and procedures 
and all participants provided informed consent. Further details regarding the wider OAI study 
protocols can be found online11. Our study included OAI participants with established 
symptomatic radiographic knee OA (n=1368), defined as both knee symptoms (pain, aching or 
stiffness in and around the knee on most days of the month for at least one month in the previous 
year12) and radiographic evidence of knee OA (Kellgren and Lawrence [KL] grade >2) in at least 
one knee. If knee OA was present in both knees then both were included in the analyses. 
 
Demographic characteristics and covariates 
Demographic characteristics collected included age, sex and race (White, Black/African 
American or Asian/other non-white). Covariates included BMI, baseline Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) pain, depression measured using the Centre 
for Epidemiological Studies Depression Scale (CES-D)13, worst baseline KL grade, baseline 
minimum medial tibiofemoral joint space width (minJSW), baseline tibial rim distance (defined 
as the distance between the anterior or posterior margin of the tibia, and the tibial margin of the 
joint space), and comorbidities assessed using the questionnaire version of the Charlson 
comorbidity index (CCI)14. The CCI derives a weighted score based on the presence or absence 
of 14 different comorbidities such as stroke, diabetes, asthma, and kidney failure, amongst 
others, and we dichotomised the cohort into those with ‘no comorbidities’ (CCI=0) and those 
with ‘one or more comorbidities’ (CCI>1) based on the total CCI score. Data on individual 
comorbidities is provided in supplementary Table 1. For descriptive purposes, we also classified 
participants as obese (>30 kg/m2), overweight (≥25 and ≤30 kg/m2) or healthy weight (<25 
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kg/m2), Scores on the CES-D were summed and a score of ≥ 16 was used to indicate significant 
depressive symptoms13. 
 
Foot/ankle symptoms 
Self-reported foot/ankle symptoms were recorded for each of the left and right feet at baseline. 
Foot/ankle symptoms were defined as pain, aching or stiffness in the foot and/or ankle on more 
than half of the days during the past 30 days, consistent with previously published definitions6, 15. 
We classified participants as having or not having foot/ankle symptoms, as well as classifying 
foot/ankle symptoms as ipsilateral, contralateral or bilateral relative to the affected knee.  
 
Outcomes 
We investigated worsening of (i) knee pain and; (ii) both knee pain and radiographic knee OA. 
Knee pain severity was determined using the WOMAC pain subscale at baseline and the 12, 24, 
36 and 48 month follow-up visits16. The WOMAC pain subscale is comprised of five items and 
responses are recorded on a 5-point Likert scale. Scores were summed (range of 0-20) and 
converted to a 0-100 normalised scale, with higher scores indicating worse pain. We defined 
knee pain worsening as an increase of at least 9 points on the 0-100 WOMAC pain scale from 
baseline at any of the subsequent follow up visits, based on previously published smallest 
detectable difference values17, 18, and consistent with recent definitions used by others 
investigating risk factors for symptomatic progression in knee OA19. People with a baseline 
WOMAC pain score >91 (and thus unable to worsen according to this definition) were excluded 
from these analyses.  
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To assess worsening of radiographic knee OA, weightbearing fixed-flexion posteroanterior 
radiographs of each knee were taken at baseline and at the 12, 24, 36 and 48 month visits. 
Radiographs were read centrally and automated software was used to identify the tibial and 
femoral margins of the knee joint from digitised copies of the radiographs20. To determine the 
minJSW, the software measured the smallest distance between the tibia and the femur in the 
medial knee joint compartment in millimeters. Worsening of radiographic knee OA was defined 
as a medial tibiofemoral minJSW decrease of >0.7mm from baseline, based on the Osteoarthritis 
Research Society International and Outcome Measures in Rheumatology minimal detectable 
difference cut-off value21. People with a baseline minJSW score of <0.7mm (and thus unable to 
worsen according to this definition) were also excluded from this analysis. A detailed outline of 
participant inclusion for each of the two aims is presented in Figure 1. 
 
Statistical analysis  
Descriptive characteristics of all variables at baseline were calculated according to the presence 
or absence of foot/ankle symptoms. Between-group differences were assessed using χ-squared 
tests, analysis of variance, Wilcoxon rank-sum or Kruskal-Wallis rank tests as appropriate.  
 
To investigate whether foot/ankle symptoms were associated with worsening of knee pain (aim 
1) and worsening of symptomatic radiographic knee OA (aim 2) over the subsequent four years, 
we used logistic regression models with the presence of foot/ankle symptoms (yes/no) as a 
binary explanatory variable. Models were fitted using generalized estimating equations to 
account for the correlation between left and right knees within participants. Models were 
performed unadjusted, as well as adjusted for baseline covariates determined a priori. The 
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covariates included in the adjusted model for aim 1 were age, sex, BMI, WOMAC pain at 
baseline, race, depression, worst baseline KL grade, and Charlson Comorbidity index 
(dichotomised), as these factors are known to be associated with both foot/ankle symptoms and 
knee OA. Models for aim 2 were also adjusted for the covariates included in the model for aim 1, 
with baseline minJSW and baseline tibial rim distance also included. 
 
Unadjusted and adjusted analyses were then repeated to investigate the association between 
ipsilateral, contralateral and bilateral foot/ankle symptoms at baseline and the worsening of knee 
pain and worsening of symptomatic radiographic knee OA. Logistic regression models were 
again fitted using generalized estimating equations to adjust for clustering of knees within 
participants. Significance was set at p-value ≤ 0.05 and Stata v12 (Stata Corporation, College 
Station, TX, USA) was used for all statistical analyses. 
 
RESULTS 
Sample characteristics 
Four participants were excluded due to having a baseline WOMAC pain score of >91 in at least 
one knee, leaving data from 1364 participants. For aim 2, an additional 95 participants with 
minJSW < 0.7mm were excluded, as were 130 participants with missing minJSW, leaving 1139 
participants for aim 2 analyses. People with foot/ankle symptoms were more likely to be female 
(p<0.001), younger (p=0.038), have a higher BMI (p=0.001) and to report more comorbidities 
(p=0.016), worse WOMAC knee pain score (p<0.001) and more depressive symptoms (p<0.001) 
at baseline than those without foot/ankle symptoms. There were no differences in race, worst KL 
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grade, or minJSW at baseline between those with and without foot/ankle symptoms. Data are 
presented in Table 1.  
 
Worsening of knee pain  
Of the 2596 knees from 1319 participants analysed, 1,280 knees from 910 participants worsened 
(Table 2). See Supplementary Table 2 for the distribution of knees and participants who reported 
pain worsening at one time point and those who reported sustained pain worsening. The presence 
of symptoms in any foot/ankle at baseline was significantly associated with knee pain worsening 
(adjusted OR 1.54, 95% CI 1.25 to 1.91). Analyses of foot/ankle symptom laterality showed that 
ipsilateral (adjusted OR 1.50, 95% CI 1.07 to 2.10), contralateral (adjusted OR 1.44, 95% CI 
1.02 to 2.06) and bilateral foot/ankle symptoms (adjusted OR 1.61, 95% CI 1.22 to 2.13) all 
significantly increased the odds for knee pain worsening in the follow up period. 
 
Worsening of symptomatic radiographic knee OA 
Of the 2005 knees from 1033 people analysed, 305 knees from 262 participants had worsening of 
both knee pain and minJSW (Table 3). See Supplementary Table 2 for the distribution of knees 
and participants who had worsening of both knee pain and minJSW at one time point and those 
who had sustained pain and minJSW worsening. The presence of symptoms in any foot/ankle at 
baseline was not significantly associated with worsening of these outcomes. Likewise, analysis 
based on foot/ankle symptoms laterality also revealed no significant associations between 
foot/ankle symptoms and worsening of both knee pain and minJSW. 
 
DISCUSSION 
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In this study, people with knee OA who also had foot/ankle symptoms were more likely to 
experience clinically relevant worsening of their knee pain at some time in the subsequent four 
years than people with knee OA but without foot/ankle symptoms. Risk for knee pain worsening 
increased regardless of foot/ankle symptom laterality. There were no longitudinal associations 
between symptoms in any foot/ankle and worsening of symptomatic radiographic knee OA. 
 
The association between knee pain progression and foot/ankle symptoms regardless of laterality 
may be explained by a number of mechanisms. For example, foot pronation is associated with 
foot pain22, and people with existing knee OA have been shown to walk with greater foot 
pronation23, potentially to allow the foot to be plantigrade to compensate for knee varus. Thus, 
given that foot pronation causes greater internal tibial rotation24, 25, this may increase rotational 
stress on the tibiofemoral joint and peri-articular structures26, exacerbating existing knee pain in 
people with knee OA. Ipsilateral and contralateral foot pronation have also been shown to 
increase the knee adduction moment24, and a higher knee adduction moment is also associated 
with greater knee pain in people with established knee OA27. Alternatively, associations between 
multiple pain locations, such as the foot and knee, may be an epiphenomenon due to an 
unmeasured shared risk factor such as fibromyalgia, pain catastrophizing, a multi-joint pain 
phenotype or generalised form of OA28. The similar odds ratios for the association between 
foot/ankle symptoms on the ipsilateral and contralateral limbs, and worsening of knee pain, 
provide some support for this theory. Finally, certain styles of footwear, such as high heels, are 
associated with a greater likelihood of foot problems29 and abnormal knee biomechanics30 known 
to increase the risk of knee pain in older adults31. 
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Although foot/ankle symptoms were associated with worsening of knee pain, there was no 
longitudinal association with worsening of both knee pain and minJSW. This may because the 
participants who experienced this outcome were a smaller subset (n=79) of those who had knee 
pain worsening, and thus the model may not have had enough power to detect a relationship. 
Alternatively, it is possible that our measure of radiographic progression (minJSW) recorded 
using x-ray was not sensitive enough to detect structural deterioration32. The use of MRI 
measures may be more suitable to detect longitudinal joint changes not evident on x-ray. There is 
some support for this from a recent study that found having a greater number of painful sites 
(including at the foot) predicted knee cartilage loss on MRI in people aged between 50 and 80 
years33. 
 
Our findings add support to the scant previous literature investigating associations between 
foot/ankle and knee OA symptoms. Symptoms at these two sites have previously been shown to 
be the most prevalent multi-joint pain pattern, and to be associated with greater functional 
limitations, than the co-occurrence of pain at the knee and any other joint6. In a cross-sectional 
study using OAI data, we showed that knee OA patients with concurrent foot/ankle symptoms 
reported worse knee pain and other OA symptoms, in addition to worse general health and 
functional measures, than knee OA patients without foot/ankle symptoms7. Our recent 
longitudinal study reported that foot/ankle symptoms are a risk factor for developing knee OA 
symptoms and symptomatic radiographic knee OA over the subsequent four years in people at-
risk of the disease34. Interestingly, this previous study found that bilateral and contralateral 
foot/ankle symptoms, but not ipsilateral foot/ankle symptoms, increased the risk of developing 
these outcomes. In contrast, we found associations between knee pain worsening and foot/ankle 
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symptoms regardless of laterality in the current study. This might suggest that different 
mechanisms underpin the associations in incident versus worsening OA.  
 
Some limitations may have influenced the findings of our study. Firstly, foot/ankle symptoms 
were self-reported and were only required to be present in the previous 30 days. Although this is 
consistent with the most widely used definitions of foot/ankle pain and/or symptoms15, a clinical 
foot assessment or more detailed foot pain questionnaire, such as the Manchester Foot Pain and 
Disability Index35 (which rates a number of different aspects of foot pain and functional 
limitations), may have yielded different results. Secondly, participants were included based on 
the presence of knee symptoms, but as there was no minimum WOMAC pain score requirement 
in our inclusion criteria,  it is possible our analyses included people who did not report any 
measureable knee pain. Further, knee pain worsening was only required to be present at one of 
the follow up visits, so our analyses included both people whose knee pain worsened temporarily 
at a single time-point as well as those with sustained pain worsening. Thirdly, potential 
mechanistic data such as foot/ankle osteoarthritis, foot posture or dynamic foot function were not 
recorded in the OAI dataset and therefore we were unable to include these variables in our 
analyses. Finally, dichotomising data such as we did with BMI and Charlson comorbidity index 
can also leave residual confounding36.  However when we repeated the analyses using fractional 
polynomials to model the continuous scores for these covariates, we found no strong evidence of 
this (see Table 3 in the supplementary analyses).  
 
In summary, this study found that people with knee OA who report foot/ankle symptoms are at 
an increased risk of knee pain worsening compared to people without foot/ankle symptoms over 
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the subsequent four years. However, foot/ankle symptoms were not associated with worsening of 
symptomatic radiographic knee OA. These findings are important given that knee pain 
worsening has been shown to be an independent predictor of future knee joint replacement 
surgery37. Furthermore, both general38 and specific39-42 causes of foot pain can be treated using 
simple conservative interventions, suggesting foot/ankle symptoms may be a modifiable risk 
factor for knee OA pain worsening. Future research should investigate whether treating 
foot/ankle symptoms in people with knee OA reduces worsening of knee pain in this population. 
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TABLES 
Table 1. Baseline characteristics of participants according to the presence of foot/ankle symptoms. One participant had 
missing foot/ankle symptoms status at baseline. Values are N (%) unless otherwise indicated. 
Characteristic 
 
Missing (n) 
No foot/ankle 
symptoms(n=1013) 
Any foot/ankle 
symptoms (n=351) 
P value† 
Sex  0   <0.001 
 
Male   477 (47.1) 113 (32.2)  
 
Female   536 (52.9) 238 (67.8)  
Mean (SD) age (years)  0 61.6 (9.1) 60.6 (8.6) 0.038 
Race:  1   0.106 
 Asian and other non-white   33 (3.3) 8 (2.3)  
 White/Caucasian   723 (71.4) 234 (66.9)  
 Black/African American   257 (25.4) 108 (30.9)  
Comorbidities:  0   0.016 
 0   711 (70.2) 222 (63.2)  
 >1   302 (29.8) 129 (36.8)  
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Median (IQR) BMI kg/m2  3 29.4 (26.4, 33.0) 31 (27.3, 34.5) <0.001 
BMI categories:  3   0.001 
 
Healthy weight 
(BMI <25 kg/m2) 
 
 151 (15.0) 29 (8.3)  
 
Overweight  
(BMI 25-30 kg/m2) 
 
 393 (38.9) 126 (35.9)  
 
Obese  
(BMI >30 kg/m2) 
 
 466 (46.1) 196 (55.8)  
Worst KL grade*   0   0.080 
 0   0 (0) 0 (0)  
 1   0 (0) 0 (0)  
 2   441 (43.5) 173 (49.3)  
 3   402 (39.7) 134 (38.2)  
 4   170 (16.8) 44 (12.5)  
Median (IQR) highest WOMAC pain score*  0 25 (10, 40) 35 (20, 50) <0.001 
Mean (SD) minimum JSW (mm)*  1 3.3 (1.6) 3.4 (1.4) 0.278 
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Depression  22   <0.001 
 No   889 (89.1) 271 (78.8)  
 Yes   109 (10.9) 73 (21.2)  
 
SD, standard deviation; IQR, interquartile range; BMI, body mass index; KL, Kellgren Lawrence; WOMAC, Western Ontario and 
McMaster Universities Osteoarthritis Index; JSW, joint space width. 
*
 Baseline values (worst value across knees for each participant) 
†
 P-values from chi-squared test for binary and categorical variables, Wilcoxon rank-sum or Kruskal-Wallis rank tests for variables 
presented as median (IQR), and analysis of variance tests for variables presented as mean (SD).
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Table 2. Logistic regression analyses for the risk of the worsening of knee pain during the four-year follow up period. Logistic 
regression models fit using generalised estimating equations to account for the clustering of knees within participants. 
 
Laterality of 
foot/ankle 
symptoms 
Total 
number 
of knees 
No knee pain 
worsening 
N (%) 
Knee pain 
worsening 
N (%) 
Risk for knee pain worsening 
Unadjusted 
OR (95% CI) 
P value 
Adjusted† 
OR (95% CI) 
P value 
No symptoms 
(ref) 
1933 1021 (77.6) 912 (71.3) 1  1  
Any side 663 295 (22.4) 368 (28.8) 1.36 (1.12 to 1.65) 0.002 1.54 (1.25 to 1.91) <0.001 
        
      Ipsilateral 157 71 (5.4) 86 (6.7) 1.33 (0.96 to 1.84) 0.089 1.50 (1.07 to 2.10) 0.017 
      Contralateral 154 67 (5.1) 87 (6.8) 1.44 (1.03 to 1.99) 0.030 1.44 (1.02 to 2.06) 0.038 
      Bilateral 352 157 (11.9) 195 (15.2) 1.35 (1.05 to 1.73) 0.019 1.61 (1.22 to 2.13) <0.001 
 
OR, odds ratios; CI, confidence intervals. 
†
 Adjusted for age, sex, BMI, WOMAC pain at baseline, race, depression, Charlson Comorbidity index (dichotomised), and worst 
baseline KL grade. 
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Table 3. Logistic regression analyses for the risk of the worsening of knee pain and minJSW during the four-year follow up 
period.  Models fit using generalized estimating equations to account for the clustering of knees within participants. 
 
Laterality of 
foot/ankle 
symptoms 
Total 
number 
of knees 
No knee pain 
or minJSW 
worsening 
N (%) 
Knee pain 
and minJSW 
worsening 
N (%) 
Risk for knee pain and minJSW worsening 
Unadjusted 
OR (95% CI) 
P value 
Adjusted† 
OR (95% CI) 
P value 
No symptoms 
(ref) 
1513 1287 (75.7) 226 (74.1) 1  1  
Any side 492 413 (24.3) 79 (25.9) 1.06 (0.79 to 1.42) 0.69 1.09 (0.80 to 1.49) 0.58 
        
   Ipsilateral 106 89 (5.2) 17 (5.6) 1.11 (0.65 to 1.88) 0.70 1.07 (0.62 to 1.87) 0.81 
   Contralateral 104 83 (4.9) 21 (6.9) 1.35 (0.82 to 2.23) 0.23 1.43 (0.86 to 2.40) 0.17 
   Bilateral 282 241 (14.2) 41 (13.4) 0.94 (0.63 to 1.40) 0.77 0.97 (0.64 to 1.48) 0.90 
 
OA, osteoarthritis; minJSW, minimal medial tibiofemoral joint space width; OR, odds ratios; CI, confidence intervals. 
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†
 Adjusted for age, sex, BMI, WOMAC pain at baseline, race, depression, Charlson Comorbidity index (dichotomised), worst baseline 
KL grade, baseline minJSW and baseline tibial rim distance.
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FIGURE REFERENCES 
 
Figure 1. Flowchart for participant inclusion and exclusion. 
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Osteoarthritis Initiative (OAI) 
participants at baseline (n=4796) 
OAI participants with knee OA 
(n=1368) 
 
Aim 2 
Progression of knee pain and radiographic knee OA. Eligible 
sample = 1139 participants  
(2278 knees) 
 Excluded: 
 Participants who had WOMAC pain score of >91 (n=4), 
joint space width < 0.7mm (n=95), or missing joint space 
width at baseline (n=130) 
  
Aim 1 
Progression of knee pain. Eligible sample = 1364 participants  
(2728 knees) 
  
Excluded: 
 Participants who had WOMAC pain score at baseline of 
>91 (i.e. unable to meet outcome definition) (n=4) 
   
